54 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
, sepsis, osteoarthritis and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
tumors, sepsis and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage activation
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
conditions.
Brian Schwartz, M.D., has served as a director since December 2020. Dr. Schwartz has wide-ranging experience as a drug development expert
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
and others.
AllocetraTM is based on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage activation and clearance of dying
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
on the discoveries of Professor Dror Mevorach, an expert on immune activity, macrophage activation and clearance of dying (apoptotic) cells, in his
6-K
EX-99.1
za15peroh2gqdqbr
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
2rg5zq rtp2nh
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-5.1
o3pxx6z
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
ui6la7
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
n8wucs
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
wnkhj2a6vd97snakl8
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
9hz x6rnslqwx3x
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
b0jy99whs2hoxaj94nl
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
6kekmxfcf7tq8 50mskd
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
F-3
EX-5.1
wp8f97k3smom
29 Apr 22
Shelf registration (foreign)
8:14am
F-3
043c9z709z
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
fwlpbxqh2cyl111hm2j
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
eqtep0p8zqr1
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am